RxDoctor Payments Data

Freda Hubbard, APRN

Family · Bowling Green, KYNPI 1508168873

Payments from drug & device makers

$7,656in general payments, 2019–2025

Across 544 payments — averaging $14.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$767
  • Lilly USA, LLC$620
  • Bayer$516
  • Pfizer$353
  • Corium, LLC$316
  • plus $4K from 53 others

What the payments were for

  • Food & beverage$7,54499%
  • Education$1121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk146$1,571
AbbVie58$767
Lilly USA, LLC48$620
Bayer57$516
Pfizer20$353
Corium, LLC23$316
Astellas Pharma US Inc10$312
Takeda Pharmaceuticals U.S.A., Inc.18$303
Amgen17$282
Ironwood Pharmaceuticals, Inc16$235
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$210
Idorsia Pharmaceuticals US Inc11$157
AstraZeneca10$141
Exact Sciences7$129
Boehringer Ingelheim7$103
Verity Pharmaceuticals Inc.4$99
Dexcom, Inc.6$92
GSK6$89
Kestra Medical Technology Services, Inc.1$88
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$88
Otsuka America Pharmaceutical, Inc.4$71
Biohaven Pharmaceutical Holding Company Ltd.4$68
Abbott3$68
Novartis3$56
Almatica Pharma LLC2$48
Ardelyx, Inc.2$48
Sanofi-aventis U.S. LLC3$47
Mirum Pharmaceuticals, Inc.2$45
Lundbeck LLC2$44
Eisai Inc.3$43
Kowa Pharmaceuticals America, Inc.2$41
Phathom Pharmaceuticals, Inc.2$40
Jazz Pharmaceuticals Inc.2$38
Teva Pharmaceuticals USA, Inc.2$36
Stryker1$33
Axsome Therapeutics, Inc.2$31
Bausch Health US, LLC2$29
Vanda Pharmaceuticals Inc.1$28
Regeneron Healthcare Solutions, Inc.1$28
Neurocrine Biosciences, Inc.1$24
Dynavax Technologies Corporation1$23
Paratek Pharmaceuticals, Inc.2$23
Nestle Healthcare Nutrition Inc.1$22
Insulet Corporation1$19
Esperion Therapeutics, Inc.1$19
Optinose US, Inc.1$18
Tolmar, Inc.1$17
Philips North America LLC1$17
Acella Pharmaceuticals, LLC1$17
Corcept Therapeutics1$17
VBI Vaccine (delaware) Inc.1$17
Vertex1$16
Amarin Pharma, Inc.1$15
Adlon Therapeutics L.p.1$15
Antares Pharma, Inc.1$14
Biohaven Pharmaceuticals, Inc.1$14
Acadia Pharmaceuticals Inc1$13
OPKO Pharmaceuticals, LLC1$12
Mannkind Corporation1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,656 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$48,257
Medicare patients
269
Services billed
6,402

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin114$106,961
OzempicSemaglutide101$105,176
TrulicityDulaglutide46$54,877
LinzessLinaclotide35$32,267
MounjaroTirzepatide30$30,446
EliquisApixaban23$28,119
XareltoRivaroxaban25$25,268
MyrbetriqMirabegron50$23,656
JanuviaSitagliptin Phosphate21$21,956
Ondansetron Hcl51$21,910
TrintellixVortioxetine Hydrobromide23$15,567
Bydureon BciseExenatide Microspheres12$10,117
Lantus SolostarInsulin Glargine,hum.Rec.Anlog43$5,648
Levothyroxine Sodium356$3,983
Solifenacin Succinate22$3,760

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$103$106,961114 claims
Novo NordiskOzempic$1,571$105,176101 claims
Lilly USA, LLCTrulicity, Mounjaro$620$85,32376 claims
AbbVieLinzess, Synthroid$767$34,14476 claims
PfizerEliquis$353$28,11923 claims
Astellas Pharma US IncMyrbetriq$312$23,65650 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Dexilant$303$19,20335 claims
AstraZenecaSymbicort$141$3,60415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,374 family providers in Kentucky.

Other family in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →